Erchonia Receives First-Ever FDA 510(K) Pain Indication Using a Violet Laser This FDA market clearance marks the 2nd received in 2019.

Posted by & filed under Press Releases.

  Melbourne, Florida October 7th, 2019 – Erchonia Corporation, the global leader in the manufacturing and development of low level laser therapy technology (“3LT®”), today announces that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) market clearance to market its EVRL low level laser for the temporary relief of chronic neck… Read more »

Kent State College of Podiatric Medicine Receives Laser Donation

Posted by & filed under Press Releases.

“It’s new technology on the market to help patients and it’s good exposure for the students”   Kent State College of Podiatric Medicine received a donation of two high-tech lasers to be used at the university and Cleveland Foot & Ankle Clinics. Erchonia Corporation, a global leader in developing low level laser therapy technology, donated… Read more »

Erchonia Donates Two High-Tech Lasers to Kent State

Posted by & filed under Press Releases.

“With many people suffering from heel pain or toenail fungus, it’s important for our future doctors to understand what treatment options are out there and how Erchonia is making a difference.”   INDEPENDENCE, OH June 3, 2019 /PRNewswire/ –Erchonia Corporation, global leader in the manufacturing and development of low-level lasers, has donated two of its… Read more »

Trevor Berry, DC, DACNB to Discuss Erchonia’s Low Level Laser Technology for Pain Treatment at the 2019 Arizona Association of Chiropractic Annual Convention on Friday, June 7

Posted by & filed under Press Releases.

“It’s very helpful for patients to have a non-thermal, painless treatment, covered by insurance. Doctors also save time with an effective and comfortable procedure for patients. The mutual needs of both doctors and patients are met with Lunula.”   PHOENIX, June 3, 2019 /PRNewswire/ — Trevor Berry, DC, DACNB today announces he will be presenting at… Read more »

Erchonia’s Lunula Laser Gains Traction in Korean Market

Posted by & filed under Press Releases.

“It’s very helpful for patients to have a non-thermal, painless treatment, covered by insurance. Doctors also save time with an effective and comfortable procedure for patients. The mutual needs of both doctors and patients are met with Lunula.”   Melbourne, Fla., May 21, 2019 — Erchonia Corporation, the global leader in low-level laser technology (“3LT”),… Read more »

Erchonia to Exhibit at 2019 Arab Health Conference in Dubai

Posted by & filed under Press Releases.

“We are very excited by the growth that we are achieving across the world and are very much looking forward to Arab Health.”   Melbourne, Fla., January 10, 2019 — Erchonia Corporation, the global leader in low level laser therapy technology (“3LT”), today announces the company will be exhibiting at the upcoming 2019 Arab Health… Read more »

Erchonia & InnerScope Hearing Technologies to Conduct FDA Clinical Trial to Treat Tinnitus with Low Level Laser Technology

Posted by & filed under Press Releases.

Erchonia Corporation today announces a joint development agreement with InnerScope Hearing Technologies to conduct clinical research and trials for the purpose of obtaining 510(k) clearances from the FDA for 3LT devices to treat hearing-related conditions, including tinnitus. “We’re hopeful our partnership with InnerScope can make a real difference in patients’ lives and eventually provide a… Read more »

CBS’s “The Doctors” Showcases the Remarkable Lunula Laser as a Solution for Nail Fungus

Posted by & filed under Press Releases.

Top-Rated Daytime Talk Show Features a Confident and Dramatic Patient Result “We know our Lunula Laser can help so many people achieve healthy, clear nail growth without experiencing any harmful side-effects” Melbourne, FL (PRWEB)October 22, 2018 Erchonia, the leading low-level laser technology manufacturer in the world today announces the company’s Lunula Laser was featured on… Read more »

Erchonia Submits Data to US FDA to Support Low-Level Laser 510(k) Market Clearance for Autism

Posted by & filed under Press Releases.

Quadruple-Blind laser study proves success in treating Autism in children and adolescents. “The results are so strong, nobody can argue them.” MELBOURNE, Fla. (PRWEB)September 05, 2018 Erchonia, the World Leader in Low Level Laser technology, announces today that they have submitted data to the US FDA to support a 510(k) market clearance for Autism. The… Read more »

Erchonia Donates One Hundred and Fifty Thousand Dollars’ worth of Low-Level Lasers to the New York College of Podiatric Medicine & Foot Center of New York

Posted by & filed under Press Releases.

Pain-Free, Non-Surgical Laser Treatment Options   MELBOURNE, Fla. (PRWEB) July 25, 2018 We are pleased to announce New York College of Podiatric Medicine (NYCPM) & Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including both Lunula Lasers and FX 635 Lasers.  NYCPM provides unrivaled excellence in podiatric medical education and clinical… Read more »